Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
|Articles|April 2, 2014
- Pharmaceutical Technology-04-02-2014
- Volume 38
- Issue 4
CLARiSUITE Software Improves Accessibility and Productivity
Author(s)Melanie Sena
CLARiSUITE Software Improves Accessibility and Productivity
Videojet Technologies has improved its CLARiSUITE software product line with the launch of CLARiSUITE WebServer Edition. The new software improves overall equipment effectiveness, by assisting manufacturers remove inefficiencies and the risk of operator error including data entry and job selection. The upgraded software helps enable manufacturers to monitor and control a specific job, line, or printer from multiple locations and is adapted to run as a service in modern IT environments with physical and virtual servers. Videojet’s CLARiSUITE WebServer software solution reduces the amount of time operators need to visit their production sites and lines, as they are able to observe the status of the printer, configure it, and download jobs over any web browser within their networked environment.
Articles in this issue
over 12 years ago
SyncOperations Software Helps Increase Workflowover 12 years ago
Drug Encapsulation for Patient-Centric Dosingover 12 years ago
The Benefits of eClinical Systems in Supply-Chain Managementover 12 years ago
Navigating the Regulatory Landscape of Combination Productsover 12 years ago
Publishing Beyond the Printed PageRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
Trending on Pharmaceutical Technology
1
France Remains One of Europe’s Leading Biotech Funding Hubs
2
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
PharmTech’s Weekly Roundup—November 6, 2026: Impurities, Supply Resilience, and AI Accountability
5